X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Fulford India with Dishman Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs DISHMAN PHARMA - Comparison Results

FULFORD INDIA    Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FULFORD INDIA DISHMAN PHARMA FULFORD INDIA/
DISHMAN PHARMA
 
P/E (TTM) x 398.8 25.1 1,589.4% View Chart
P/BV x 6.2 3.3 185.7% View Chart
Dividend Yield % 0.1 0.7 12.7%  

Financials

 FULFORD INDIA   DISHMAN PHARMA
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
DISHMAN PHARMA
Mar-16
FULFORD INDIA/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs942374 251.6%   
Low Rs450129 349.1%   
Sales per share (Unadj.) Rs691.4197.8 349.5%  
Earnings per share (Unadj.) Rs11.521.2 54.0%  
Cash flow per share (Unadj.) Rs15.434.7 44.2%  
Dividends per share (Unadj.) Rs2.002.00 100.0%  
Dividend yield (eoy) %0.30.8 36.2%  
Book value per share (Unadj.) Rs380.0179.9 211.2%  
Shares outstanding (eoy) m3.9080.69 4.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.01.3 79.1%   
Avg P/E ratio x60.711.9 511.7%  
P/CF ratio (eoy) x45.37.2 625.2%  
Price / Book Value ratio x1.81.4 130.9%  
Dividend payout %17.49.4 185.0%   
Avg Mkt Cap Rs m2,71420,306 13.4%   
No. of employees `0000.40.8 53.6%   
Total wages/salary Rs m5055,355 9.4%   
Avg. sales/employee Rs Th6,073.019,252.7 31.5%   
Avg. wages/employee Rs Th1,137.46,459.5 17.6%   
Avg. net profit/employee Rs Th100.72,064.1 4.9%   
INCOME DATA
Net Sales Rs m2,69615,961 16.9%  
Other income Rs m125265 47.2%   
Total revenues Rs m2,82216,226 17.4%   
Gross profit Rs m-464,103 -1.1%  
Depreciation Rs m151,091 1.4%   
Interest Rs m10944 1.0%   
Profit before tax Rs m542,334 2.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m10624 1.5%   
Profit after tax Rs m451,711 2.6%  
Gross profit margin %-1.725.7 -6.7%  
Effective tax rate %17.726.7 66.2%   
Net profit margin %1.710.7 15.5%  
BALANCE SHEET DATA
Current assets Rs m1,73811,018 15.8%   
Current liabilities Rs m5459,517 5.7%   
Net working cap to sales %44.39.4 470.7%  
Current ratio x3.21.2 275.7%  
Inventory Days Days48110 43.9%  
Debtors Days Days435 12.4%  
Net fixed assets Rs m1216,304 0.1%   
Share capital Rs m39161 24.2%   
"Free" reserves Rs m1,44312,907 11.2%   
Net worth Rs m1,48214,516 10.2%   
Long term debt Rs m04,189 0.0%   
Total assets Rs m2,07729,805 7.0%  
Interest coverage x6.73.5 193.5%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x1.30.5 242.5%   
Return on assets %2.68.9 29.3%  
Return on equity %3.011.8 25.6%  
Return on capital %4.317.5 24.6%  
Exports to sales %024.8 0.0%   
Imports to sales %24.53.7 654.4%   
Exports (fob) Rs mNA3,956 0.0%   
Imports (cif) Rs m659596 110.6%   
Fx inflow Rs m174,952 0.3%   
Fx outflow Rs m673697 96.6%   
Net fx Rs m-6564,255 -15.4%   
CASH FLOW
From Operations Rs m902,786 3.2%  
From Investments Rs m105-1,529 -6.8%  
From Financial Activity Rs m-14-941 1.5%  
Net Cashflow Rs m181316 57.0%  

Share Holding

Indian Promoters % 0.0 61.4 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 3.8 3.7 102.7%  
FIIs % 0.1 12.7 0.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.2 22.1 95.9%  
Shareholders   4,783 46,261 10.3%  
Pledged promoter(s) holding % 0.0 35.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FULFORD INDIA With:   ELDER PHARMA  FDC LTD.  SHASUN PHARMA  STRIDES SHASUN LTD  TTK HEALTHCARE  

Compare FULFORD INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Global Stock Markets Rebound After Sharp Weekly Drop(RoundUp)

Global financial markets rallied this week and brushed aside a rise in global borrowing costs while the dollar hit its lowest level since 2014.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

As the Market Corrects... It's Time to Buy More(Smart Contrarian)

Feb 5, 2018

The recent sell off in the stock market offers buying opportunity in some quality small caps.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

What Should Mutual Fund Investors Do After LTCG Tax Norms(Outside View)

Feb 6, 2018

PersonalFN explain what investors should after LTCG tax norms.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA - IPCA LABS COMPARISON

COMPARE FULFORD INDIA WITH

MARKET STATS